Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2005
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1204669B1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1189605B1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1019089B1 Long-acting drugs and pharmaceutical compositions comprising them
11/09/2005EP0844874B1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS
11/09/2005EP0751992B1 Vascular endothelial growth factor 2
11/09/2005CN1694901A Kdr peptides and vaccines comprising the same
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694881A New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694876A Dibenzoxazepine
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694707A Pde-v inhibitor and medicine composite with active agent
11/09/2005CN1694702A Neurotrophic factor production promoter
11/09/2005CN1694699A Percutaneous absorption preparations containing 3-methyl-phenyl-2-pyrazolin-5-one
11/09/2005CN1694697A Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for
11/09/2005CN1694693A Blood fluidity improving agent
11/09/2005CN1692911A Application of cilostazol for preparing medicine to treat bradycardia
11/09/2005CN1692908A Application of timosaponin B II for preparing medicine or products for treating and preventing stroke
11/09/2005CN1226410C CR1 gene related to cell reconstitution, conduction and death
11/09/2005CN1226292C Diazesuberane derivant or its salt
11/09/2005CN1226290C Ligands of nuclear receptor
11/09/2005CN1226039C Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962978 Multiple sclerosis; immobilization; water solubility
11/08/2005US6962942 Azacycloalkanone serine protease inhibitors
11/08/2005US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
11/08/2005US6962939 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962928 such as 6-methoxy-2-(4-methoxyphenyl)-1-[4-(2-piperidin-1-yl-ethyoxy)-phenyl]-1,2,3,4-tetrahydroquinoline
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962911 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
11/08/2005US6962908 Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
11/08/2005US6962905 Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/08/2005US6962903 Modified annexin proteins and methods for preventing thrombosis
11/08/2005CA2221255C Use of selegiline to treat hearing loss in mammals
11/08/2005CA2195677C Endothelin antagonists
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103076A2 Erythropoietin protein variants
11/03/2005WO2005103046A1 Selenophen derivatives and the use of preventing and/or treating the diseases relating to protein aging thereof
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102981A1 Novel compounds and medicinal use thereof
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005102339A1 The use of cilostazol in preparing the medicine for bradycardia treatment
11/03/2005WO2005102314A1 The use of butylphthalide homologues in preparing the drug of preventing and treating cerebral ischemic
11/03/2005WO2005102304A1 Methods and compositions for the treatment of myocardial conditions
11/03/2005WO2005002555A3 Sirt1 modulators for manipulating cell/organism lifespan/stress response
11/03/2005WO2004082675A8 Method for increasing the oral bioavailability of s-[2- ([[1- (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] 2-methylpropanethioate
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245736 Low molecular weight oversulfated polysaccharide
11/03/2005US20050245731 DNA encoding tumor necrosis factor inhibitory protein and its use
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245584 Peroxisome proliferator activated receptor agonists
11/03/2005US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245574 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof
11/03/2005US20050245572 Naphthyl ether compounds and their use
11/03/2005US20050245570 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245565 Diamine derivatives
11/03/2005US20050245553 Amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl chloromethanesulfonate; cardiovascular disorders, thromboembolic disorders, inflammation, and disorders of the central nervous system
11/03/2005US20050245552 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245549 Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245514 Novel physiologically active substances
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245488 Pharmaceutically active compounds and methods of use thereof
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244526 Use of a preparation produced from plant seedlings, enriched with electrolyte
11/03/2005US20050244514 Flavone and adenosine from Ixeris Sonchifolia Hance is more stable in the lyophilized powder form than in liquid form for injection so that it is easy to control the quality of the product so as to make the medicament safe and effective
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244382 Compositions including ammonia oxidizing bacteria and methods of using same
11/03/2005US20050244376 Modified viral surface proteins for binding to extracellular matrix components
11/03/2005US20050244298 Electrocardiographic aspects of chf treatment
1 ... 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 ... 1595